CHARACTERIZATION AND REGULATION OF PROSTAGLANDIN E(2) RECEPTORS ON NORMAL AND MALIGNANT MURINE B-LYMPHOCYTES

被引:25
作者
BROWN, DM
PHIPPS, RP
机构
[1] UNIV ROCHESTER,SCH MED,CTR CANC,DEPT MICROBIOL & IMMUNOL,ROCHESTER,NY 14642
[2] UNIV ROCHESTER,SCH MED,CTR CANC,DEPT PEDIAT,ROCHESTER,NY 14642
关键词
D O I
10.1006/cimm.1995.1011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostaglandin E(2) (PGE(2)) is a pleiotropic lipid molecule synthesized by macrophages, follicular dendritic cells, and fibroblasts, inhabitants of the B cell microenvironment. It is a potent regulator of B lymphocyte functions including activation and immunoglobulin class switching. To understand the effects of PGE(2) on B lymphocyte function, the features of the putative PGE(2) receptor on cells of the B lineage must be delineated, This receptor has not yet been characterized on B lymphocytes, Murine B cell lymphomas were used as a model to evaluate B lineage PGE(2) receptors since they elevate intracellular cAMP in response to PGE(2). Scatchard analysis indicates that the PGE(2) receptor on both CH31 and CH12 exists in a single high-affinity state, with the CH12 B lymphoma possessing three times more receptors per cell compared to CH31. Interestingly, the PGE(2) receptor is subject to regulation as a 20-hr LPS treatment increased PGE(2) receptor number by two- to threefold on CH12 and CH31 B cell lymphomas, while dissociation constants remained similar. Finally, Scatchard analysis of normal murine splenic B lymphocytes demonstrates that they also possess high-affinity receptors for PGE(2). Treatment of normal B cells with IL-4 increased PGE(2) receptor levels fourfold from approximately 50 to 200 sites/cell while the affinity of the receptor slightly decreased. These results are the first to describe the number and affinity of PGE(2) receptors on cells of the B lineage. These findings also suggest that B lymphocyte-activating molecules such as LPS and IL-4 may enhance sensitivity to PGE(2) by upregulating the number of PGE(2) receptors on B cells, Moreover, these observations may be of importance in developing strategies to specifically control the spread of PGE(2)-sensitive B lymphomas. (C) 1995 Academic Press, Inc.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 42 条
  • [1] BETZ M, 1991, J IMMUNOL, V146, P108
  • [2] BORRELLO MA, 1993, IMMUNOMETHODS, V2, P261
  • [3] PROSTAGLANDIN-E2 INDUCES APOPTOSIS IN IMMATURE NORMAL AND MALIGNANT LYMPHOCYTES-B
    BROWN, DM
    WARNER, GL
    ALESMARTINEZ, JE
    SCOTT, DW
    PHIPPS, RP
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 63 (03): : 221 - 229
  • [4] COLEMAN RA, 1987, PROSTAGLANDINS RELAT, P267
  • [5] FERNANDEZBOTRAN R, 1984, J IMMUNOL, V133, P2662
  • [6] FC-GAMMA-RECEPTOR-MEDIATED CHANGES IN THE PLASMA-MEMBRANE POTENTIAL INDUCE PROSTAGLANDIN RELEASE FROM HUMAN-FIBROBLASTS
    FREY, J
    JANES, M
    ENGELHARDT, W
    AFTING, EG
    GEERDS, C
    MOLLER, B
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 158 (01): : 85 - 89
  • [7] GAJEWSKI TF, 1990, J IMMUNOL, V144, P4110
  • [8] GOODWIN JS, 1977, NEW ENGL J MED, V297, P963, DOI 10.1056/NEJM197711032971802
  • [9] HEINEN E, 1986, ANN INST PASTEUR IMM, VD137, P369
  • [10] EXPRESSION OF GTP-BINDING PROTEINS AND PROSTAGLANDIN-E2 RECEPTORS DURING HUMAN T-CELL ACTIVATION
    HOLTER, W
    SPIEGEL, AM
    HOWARD, BH
    WEBER, S
    BRANN, MR
    [J]. CELLULAR IMMUNOLOGY, 1991, 134 (02) : 287 - 295